Home › NDC Lookup › RxCUI directory › RxCUI 313219

Terazosin 5 MG Oral Capsule — RxCUI 313219

RxNorm drug concept · Semantic clinical drug
RxCUI 313219 Semantic clinical drug · SCD ● Current RxNorm concept 49 FDA products 104 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313219
Official nameTerazosin 5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asterazosin (as terazosin hydrochloride) 5 MG Oral Capsule; terazosin HCl 5 MG Oral Capsule
FDA products mapped49
Package NDCs mapped104
Reported Medicaid activity (SDUD)62,766 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Terazosin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats symptoms of an enlarged prostate (BPH) and high blood pressure. Your prescriber will tell you which one you are taking it for.
  • The first dose can drop your blood pressure and cause dizziness or fainting. Taking it at bedtime lowers the chance of an injury. Avoid driving or hazardous tasks for 12 hours afte...
  • Why do I take the first dose at bedtime?
  • Do not just jump back to your usual dose. After more than a few days off, the label says to restart with the starting regimen. Call your prescriber or me for guidance.
📖 Read our full Terazosin guide →

🕸️ Concept Web — How Terazosin 5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Terazosin 5 MG Oral Capsule RxCUI 313219

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Terazosin 37798
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Terazosin Oral Capsule 374033
    • Terazosin Oral Product 1164232
    • Terazosin Pill 1164233
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Terazosin 5 MG 330521

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Terazosin 5 MG SCDC · 330521
  • Terazosin Oral Capsule SCDF · 374033
  • Terazosin Oral Product SCDG · 1164232
  • Terazosin Pill SCDG · 1164233

📦 FDA Products & Package NDCs

49 products · 104 package NDCs
104 package NDCs map to RxCUI 313219 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
23155-0735-01 100 CAPSULE in 1 BOTTLE (23155-735-01) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0735-10 1000 CAPSULE in 1 BOTTLE (23155-735-10) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0736-01 100 CAPSULE in 1 BOTTLE (23155-736-01) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0736-10 1000 CAPSULE in 1 BOTTLE (23155-736-10) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0737-01 100 CAPSULE in 1 BOTTLE (23155-737-01) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0737-10 1000 CAPSULE in 1 BOTTLE (23155-737-10) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0738-01 100 CAPSULE in 1 BOTTLE (23155-738-01) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
23155-0738-10 1000 CAPSULE in 1 BOTTLE (23155-738-10) terazosin Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-04-30
27241-0288-01 100 CAPSULE in 1 BOTTLE (27241-288-01) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0288-10 1000 CAPSULE in 1 BOTTLE (27241-288-10) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0289-01 100 CAPSULE in 1 BOTTLE (27241-289-01) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0289-10 1000 CAPSULE in 1 BOTTLE (27241-289-10) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0290-01 100 CAPSULE in 1 BOTTLE (27241-290-01) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0290-10 1000 CAPSULE in 1 BOTTLE (27241-290-10) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0291-01 100 CAPSULE in 1 BOTTLE (27241-291-01) Terazosin Ajanta Pharma USA Inc. 2025-05-12
27241-0291-10 1000 CAPSULE in 1 BOTTLE (27241-291-10) Terazosin Ajanta Pharma USA Inc. 2025-05-12
42291-0820-10 1000 CAPSULE in 1 BOTTLE (42291-820-10) Terazosin AvKARE 2020-03-30
42291-0821-10 1000 CAPSULE in 1 BOTTLE (42291-821-10) Terazosin AvKARE 2020-03-30
42291-0822-10 1000 CAPSULE in 1 BOTTLE (42291-822-10) Terazosin AvKARE 2020-03-30
42291-0823-10 1000 CAPSULE in 1 BOTTLE (42291-823-10) Terazosin AvKARE 2020-03-30
50090-1559-00 30 CAPSULE in 1 BOTTLE (50090-1559-0) Terazosin A-S Medication Solutions 2014-12-19
50090-1559-01 90 CAPSULE in 1 BOTTLE (50090-1559-1) Terazosin A-S Medication Solutions 2014-12-19
50090-2371-00 30 CAPSULE in 1 BOTTLE (50090-2371-0) Terazosin A-S Medication Solutions 2018-10-11
50090-2623-00 30 CAPSULE in 1 BOTTLE (50090-2623-0) Terazosin A-S Medication Solutions 2016-11-16
50090-2623-01 90 CAPSULE in 1 BOTTLE (50090-2623-1) Terazosin A-S Medication Solutions 2018-08-30
50268-0764-15 50 BLISTER PACK in 1 BOX (50268-764-15) / 1 CAPSULE in 1 BL... Terazosin AvPAK 2020-02-13
50268-0765-15 50 BLISTER PACK in 1 BOX (50268-765-15) / 1 CAPSULE in 1 BL... Terazosin AvPAK 2020-02-13
50268-0766-15 50 BLISTER PACK in 1 BOX (50268-766-15) / 1 CAPSULE in 1 BL... Terazosin AvPAK 2020-02-13
50268-0767-15 50 BLISTER PACK in 1 BOX (50268-767-15) / 1 CAPSULE in 1 BL... Terazosin AvPAK 2020-02-13
59746-0383-06 100 CAPSULE in 1 BOTTLE (59746-383-06) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0383-09 500 CAPSULE in 1 BOTTLE (59746-383-09) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0383-10 1000 CAPSULE in 1 BOTTLE (59746-383-10) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0383-90 90 CAPSULE in 1 BOTTLE (59746-383-90) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0384-06 100 CAPSULE in 1 BOTTLE (59746-384-06) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0384-09 500 CAPSULE in 1 BOTTLE (59746-384-09) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0384-10 1000 CAPSULE in 1 BOTTLE (59746-384-10) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0384-90 90 CAPSULE in 1 BOTTLE (59746-384-90) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0385-06 100 CAPSULE in 1 BOTTLE (59746-385-06) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0385-09 500 CAPSULE in 1 BOTTLE (59746-385-09) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0385-10 1000 CAPSULE in 1 BOTTLE (59746-385-10) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0385-90 90 CAPSULE in 1 BOTTLE (59746-385-90) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0386-06 100 CAPSULE in 1 BOTTLE (59746-386-06) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0386-09 500 CAPSULE in 1 BOTTLE (59746-386-09) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0386-10 1000 CAPSULE in 1 BOTTLE (59746-386-10) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2004-12-20
59746-0386-90 90 CAPSULE in 1 BOTTLE (59746-386-90) Terazosin Jubilant Cadista Pharmaceuticals Inc. 2006-12-20
62135-0458-90 90 CAPSULE in 1 BOTTLE (62135-458-90) Terazosin Chartwell RX, LLC 2023-02-01
62135-0459-90 90 CAPSULE in 1 BOTTLE (62135-459-90) Terazosin Chartwell RX, LLC 2023-02-01
62135-0460-90 90 CAPSULE in 1 BOTTLE (62135-460-90) Terazosin Chartwell RX, LLC 2023-02-01
62135-0461-90 90 CAPSULE in 1 BOTTLE (62135-461-90) Terazosin Chartwell RX, LLC 2023-02-01
63187-0456-90 90 CAPSULE in 1 BOTTLE (63187-456-90) Terazosin Proficient Rx LP 2018-12-01
Observed labelers: Jubilant Cadista Pharmaceuticals Inc. (16) · Aphena Pharma Solutions - Tennessee, LLC (15) · Preferred Pharmaceuticals, Inc (12) · Bryant Ranch Prepack (9) · Ajanta Pharma USA Inc. (8) · Amici Pharma, Inc. (8) · +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.